Buruli ulcer lesions in HIV-positive patient.
Kibadi
Kapay
K
Colebunders
Robert
R
Muyembe-Tamfum
Jean-Jacques
JJ
Meyers
Wayne M
WM
Portaels
Françoise
F
D017088:AIDS-Related Opportunistic Infections / Q000453:epidemiology* / Q000382:microbiology; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000904:Antibiotics, Antitubercular / Q000627:therapeutic use; D054312:Buruli Ulcer / Q000188:drug therapy / Q000453:epidemiology* / Q000209:etiology; D004359:Drug Therapy, Combination; D006801:Humans; D008297:Male; D012293:Rifampin / Q000627:therapeutic use; D013307:Streptomycin / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D000904:Antibiotics, Antitubercular; D012293:Rifampin; D013307:Streptomycin